Literature DB >> 20104599

Epidemiology of holoprosencephaly: Prevalence and risk factors.

Iêda M Orioli1, Eduardo E Castilla.   

Abstract

The wide variation in cerebral and facial phenotypes and the recognized etiologic heterogeneity of holoprosencephaly (HPE) contribute to the observed inter-study heterogeneity. High lethality during the early stages of embryonic and fetal development makes HPE detection age dependent. By reviewing 21 HPE epidemiologic articles, the observed prevalence rate differences can be largely explained by the pregnancy outcome status of the studied cohort: livebirth, stillbirth, and terminations of pregnancy (TOPs): lower than 1 per 10,000 when live and still births were included, higher when TOPs were included, and between 40 and 50 per 10,000 in two classical Japanese studies on aborted embryos. The increasing secular trend observed in some studies probably resulted from an increasing use of prenatal sonography. Ethnic variations in birth prevalence rates (BPRs) could occur in HPE, but the available data are not very convincing. Higher BPRs were generally observed in the less favored minorities (Blacks, Hispanics, Pakistanis), suggesting a bias caused by a lower prenatal detection rate of HPE, and consequently less TOPs. Severe ear defects, as well as microstomia, were part of the spectrum of HPE. Non-craniofacial anomalies, more frequently associated with HPE than expected, were genital anomalies (24%), postaxial polydactyly (8%), vertebral defects (5%), limb reduction defects (4%), and transposition of great arteries (4%). The variable female predominance, found in different HPE studies, could also depend on the proportion of early conceptions in each study sample, as males are more likely to be lost through spontaneous abortions. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20104599     DOI: 10.1002/ajmg.c.30233

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  28 in total

Review 1.  Holoprosencephaly-polydactyly/pseudotrisomy 13: a presentation of two new cases and a review of the literature.

Authors:  Sophia M Bous; Benjamin D Solomon; Luitgard Graul-Neumann; Heidemarie Neitzel; Emily E Hardisty; Maximilian Muenke
Journal:  Clin Dysmorphol       Date:  2012-10       Impact factor: 0.816

2.  Clinical utility gene card for: Holoprosencephaly.

Authors:  Christèle Dubourg; Véronique David; Andrea Gropman; Sandra Mercier; Maximilian Muenke; Sylvie Odent; Daniel E Pineda-Alvarez; Erich Roessler
Journal:  Eur J Hum Genet       Date:  2010-07-21       Impact factor: 4.246

Review 3.  Cyclopia: an epidemiologic study in a large dataset from the International Clearinghouse of Birth Defects Surveillance and Research.

Authors:  Iêda M Orioli; Emmanuelle Amar; Marian K Bakker; Eva Bermejo-Sánchez; Fabrizio Bianchi; Mark A Canfield; Maurizio Clementi; Adolfo Correa; Melinda Csáky-Szunyogh; Marcia L Feldkamp; Danielle Landau; Emanuele Leoncini; Zhu Li; R Brian Lowry; Pierpaolo Mastroiacovo; Margery Morgan; Osvaldo M Mutchinick; Anke Rissmann; Annukka Ritvanen; Gioacchino Scarano; Elena Szabova; Eduardo E Castilla
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-10-17       Impact factor: 3.908

4.  Minimal evidence for a direct involvement of twisted gastrulation homolog 1 (TWSG1) gene in human holoprosencephaly.

Authors:  Emily F Kauvar; Ping Hu; Daniel E Pineda-Alvarez; Benjamin D Solomon; Amalia Dutra; Evgenia Pak; Brooke Blessing; Virginia Proud; Alan L Shanske; Cathy A Stevens; Jill A Rosenfeld; Lisa G Shaffer; Erich Roessler; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2010-12-21       Impact factor: 4.797

5.  New findings for phenotype-genotype correlations in a large European series of holoprosencephaly cases.

Authors:  Sandra Mercier; Christèle Dubourg; Nicolas Garcelon; Boris Campillo-Gimenez; Isabelle Gicquel; Marion Belleguic; Leslie Ratié; Laurent Pasquier; Philippe Loget; Claude Bendavid; Sylvie Jaillard; Lucie Rochard; Chloé Quélin; Valérie Dupé; Véronique David; Sylvie Odent
Journal:  J Med Genet       Date:  2011-09-22       Impact factor: 6.318

6.  The Use of Variant Maps to Explore Domain-Specific Mutations of FGFR1.

Authors:  L A Lansdon; H V Bernabe; N Nidey; J Standley; M J Schnieders; J C Murray
Journal:  J Dent Res       Date:  2017-08-21       Impact factor: 6.116

7.  Novel heterozygous variants in KMT2D associated with holoprosencephaly.

Authors:  Cedrik Tekendo-Ngongang; Paul Kruszka; Ariel F Martinez; Maximilian Muenke
Journal:  Clin Genet       Date:  2019-07-15       Impact factor: 4.438

Review 8.  Holoprosencephaly: a guide to diagnosis and clinical management.

Authors:  Manu S Raam; Benjamin D Solomon; Maximilian Muenke
Journal:  Indian Pediatr       Date:  2011-06       Impact factor: 1.411

9.  Beyond Gómez-López-Hernández syndrome: recurring phenotypic themes in rhombencephalosynapsis.

Authors:  Hannah M Tully; Jennifer C Dempsey; Gisele E Ishak; Margaret P Adam; Cynthia J R Curry; Pedro Sanchez-Lara; Alasdair Hunter; Karen W Gripp; Judith Allanson; Christopher Cunniff; Ian Glass; Kathleen J Millen; Daniel Doherty; William B Dobyns
Journal:  Am J Med Genet A       Date:  2012-09-10       Impact factor: 2.802

Review 10.  Extracephalic manifestations of nonchromosomal, nonsyndromic holoprosencephaly.

Authors:  Ariel F Martinez; Paul S Kruszka; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-05-15       Impact factor: 3.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.